{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:46:12Z","timestamp":1760298372050},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2011,6,17]],"date-time":"2011-06-17T00:00:00Z","timestamp":1308268800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s11095-011-0490-x","type":"journal-article","created":{"date-parts":[[2011,6,17]],"date-time":"2011-06-17T21:27:51Z","timestamp":1308346071000},"page":"2610-2627","source":"Crossref","is-referenced-by-count":10,"title":["Modeling Sleep Data for a New Drug in Development using Markov Mixed-Effects Models"],"prefix":"10.1007","volume":"28","author":[{"given":"Maria C.","family":"Kjellsson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Ouellet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Corrigan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mats O.","family":"Karlsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,6,17]]},"reference":[{"key":"490_CR1","volume-title":"A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects","author":"A Rechtschaffen","year":"1968","unstructured":"Rechtschaffen A, Kales A. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Los Angeles: U.B.I.S.B.R. Institute; 1968."},{"key":"490_CR2","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/sleep\/9.3.405","volume":"9","author":"B Kemp","year":"1986","unstructured":"Kemp B, Kamphuisen HA. Simulation of human hypnograms using a Markov chain. Sleep. 1986;9:405\u201314.","journal-title":"Sleep"},{"key":"490_CR3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1067\/mcp.2000.108669","volume":"68","author":"MO Karlsson","year":"2000","unstructured":"Karlsson MO, Schoemaker RC, Kemp B, Cohne AF, van Gerven JM, Tuk B, et al. A pharmacodynamic Markov mixed-effects model for the effect of temazepam on sleep. Clin Pharmacol Ther. 2000;68:175\u201388.","journal-title":"Clin Pharmacol Ther"},{"key":"490_CR4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10928-009-9148-2","volume":"37","author":"R Bizzotto","year":"2010","unstructured":"Bizzotto R, Zamuner S, de Nicolao G, Karlsson MO, Gomeni R. Multinomial logistic estimation of Markov-chain models for modeling sleep architecture in primary insomnia patients. J Pharmacokinet Pharmacodyn. 2010;37:137\u201355.","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"490_CR5","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.tips.2006.12.006","volume":"28","author":"DJ Dooley","year":"2007","unstructured":"Dooley DJ, Taylor CP, Donevan S, Feltner D. Ca2+ channel alpha2delta ligands: novel modulators of neurotransmission. Trends Pharmacol Sci. 2007;28:75\u201382.","journal-title":"Trends Pharmacol Sci"},{"key":"490_CR6","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0009-9236(98)90139-4","volume":"64","author":"DJ Greenblatt","year":"1998","unstructured":"Greenblatt DJ, Harmatz JS, von Moltke LL, Ehrenberg BL, Harrel L, Corbett K, et al. Comparative kinetics and dynamics of zaleplon, zolpidem and placebo. Clin Pharmacol Ther. 1998;64:553\u201361.","journal-title":"Clin Pharmacol Ther"},{"issue":"S1","key":"490_CR7","first-page":"PI-69","volume":"83","author":"B Corrigan","year":"2008","unstructured":"Corrigan B, Werth J, Bramson C, Alvey C, Abel R, Feltner D, et al. Pharmacokinetics and pharmacodynamics of PD 0200390 following single dose administration to healthy volunteers. Clin Pharmacol Ther. 2008;83(S1):PI-69.","journal-title":"Clin Pharmacol Ther"},{"issue":"S1","key":"490_CR8","first-page":"PI-71","volume":"83","author":"B Corrigan","year":"2008","unstructured":"Corrigan B, Werth J, Moton A, Alvey C, Feltner D, Ouellet D. Pharmacokinetics of PD 0200390 following multiple dose administration to healthy volunteers. Clin Pharmacol Ther. 2008;83(S1):PI-71.","journal-title":"Clin Pharmacol Ther"},{"key":"490_CR9","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/cpt1979253358","volume":"25","author":"LB Sheiner","year":"1979","unstructured":"Sheiner LB, Stanski DR, Vozeh S, Miller RD, Ham J. Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine. Clin Pharmacol Ther. 1979;25:358\u201371.","journal-title":"Clin Pharmacol Ther"},{"key":"490_CR10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3109\/03602539208996294","volume":"24","author":"A Durand","year":"1992","unstructured":"Durand A, Th\u00e9not JT, Bianchetti G, Morselli PL. Comparative pharmacokinetic profile of two imidazopyridine drugs: zolpidem and alpidem. Drug Metab Rev. 1992;24:239\u201366.","journal-title":"Drug Metab Rev"},{"key":"490_CR11","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/BF02245455","volume":"114","author":"A Patat","year":"1994","unstructured":"Patat A, Trocherie S, Thebault JJ, Rosenzweig P, Dubrac C, Bianchetti G, et al. EEG profile of intravenous zolpidem in healthy volunteers. Psychopharmacology (Berl). 1994;114:138\u201346.","journal-title":"Psychopharmacology (Berl)"},{"key":"490_CR12","doi-asserted-by":"crossref","first-page":"865","DOI":"10.2165\/00003495-200059040-00014","volume":"59","author":"KJ Holm","year":"2000","unstructured":"Holm KJ, Goa KL. Zolpidem, An update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia. Drug. 2000;59:865\u201389.","journal-title":"Drug"},{"key":"490_CR13","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2165\/00003088-200443040-00002","volume":"43","author":"DR Dover","year":"2004","unstructured":"Dover DR. Comparative pharmacokinetics and pharmacodynamics of short-acting hypnosedatives. Zaleplon, zolpidem and zopiclone. Clin Pharmacokinet. 2004;43:227\u201338.","journal-title":"Clin Pharmacokinet"},{"key":"490_CR14","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1208\/s12248-009-9133-0","volume":"11","author":"RM Savic","year":"2009","unstructured":"Savic RM, Karlsson MO. Importance of shrinkage in empirical bayes estimates for diagnostics: problems and solutions. AAPS J. 2009;11:558\u201369.","journal-title":"AAPS J"},{"key":"490_CR15","volume-title":"R: A language and environment for statistical computing","author":"R Development Core Team","year":"2005","unstructured":"R Development Core Team. R: A language and environment for statistical computing. Vienna: R foundation for statistical computing; 2005."},{"key":"490_CR16","unstructured":"Beal SL, Sheiner LB (eds). NONMEM Users Guides. Elliot City, Maryland, USA: Icon Development Solutions; 1989\u201398."},{"key":"490_CR17","doi-asserted-by":"crossref","DOI":"10.1201\/9780429258411","volume-title":"Bayesian data analysis","author":"A Gelman","year":"1995","unstructured":"Gelman A, Carlin JB, Stern HS. Bayesian data analysis. London: Chapman & Hall; 1995."},{"key":"490_CR18","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1002\/(SICI)1097-0258(19981030)17:20<2313::AID-SIM935>3.0.CO;2-V","volume":"17","author":"P Girard","year":"1998","unstructured":"Girard P, Blaschke TF, Kastrissios H, Sheiner LB. A Markov mixed effect regression model for drug compliance. Stat Med. 1998;17:2313\u201333.","journal-title":"Stat Med"},{"key":"490_CR19","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1469-8986.1966.tb02650.x","volume":"2","author":"HM Agnew","year":"1966","unstructured":"Agnew HM, Webb WB, Williams RL. The first night effect: an EEG study of sleep. Psychophysiology. 1966;2:263\u20136.","journal-title":"Psychophysiology"},{"key":"490_CR20","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1023\/A:1011970125687","volume":"15","author":"EN Jonsson","year":"1998","unstructured":"Jonsson EN, Karlsson MO. Automated covariate model building within NONMEM. Pharm Res. 1998;15:1463\u20138.","journal-title":"Pharm Res"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-011-0490-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11095-011-0490-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-011-0490-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T07:39:07Z","timestamp":1592638747000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-011-0490-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,17]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["490"],"URL":"https:\/\/doi.org\/10.1007\/s11095-011-0490-x","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,17]]}}}